Naturally occurring Arg-1 to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C

Blood

Volumn 89, Issue 8, 1997, Pages 2807-2816

  Lind, Bent ^a   Johnsen, Anders H ^a   Thorsen, Sixtus ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ARGININE; BLOOD CLOTTING FACTOR 5; DNA; FIBRINOGEN; HISTIDINE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXYLATION; CASE REPORT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENE MUTATION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN ISOLATION; PROTEIN METHYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SECRETION; THROMBIN TIME;

EID: 0030894792     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2807     Document Type: Article

References (49)

1. Esmon CT: The protein C anticoagulant pathway. Arterioscler Thromb 12:135, 1992
2. Dahlbäck B: The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 77:1, 1995
3. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E: Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341:134, 1993
4. Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN: Protein C deficiency: a database of mutations, 1995 update. Thromb Haemost 73:876, 1995
5. Furie B, Furie BC: Molecular and cellular biology of blood coagulation. N Engl J Med 326:800, 1992
6. Reiner AP, Davie EW: Introduction to hemostasis and the vitamin K-dependent coagulation factors, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 1995, p 3181
7. Suttie JW: Synthesis of vitamin K-dependent proteins. FASEB J 7:445, 1993
8. Furie B, Furie BC: Molecular basis of vitamin K-dependent γ-carboxylation. Blood 75:1753, 1990
9. 2+-free GLA domain sheds light on membrane binding of blood coagulation proteins. Nat Struct Biol 2:504, 1995
10. Welsch DJ, Nelsestuen GL: Amino-terminal alanine functions in a calcium-specific process essential for membrane binding by prothrombin fragment 1. Biochemistry 27:4939, 1988
11. Soriana-Garcia M, Padmanabhan K, De Vos AM, Tulinsky A: The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 31:2554, 1992
12. Freedman SJ, Furie BC, Furie B, Baleja JD: Structure of the metal-free γ-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J Biol Chem 270:7980, 1995
13. Christiansen WT, Jalbert LR, Robertson RM, Jhingan A, Prorok M, Castellino FJ: Hydrophobic amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid vesicles. Biochemistry 34:10376, 1995
14. Wasley LC, Rehemtulla A, Bristol JA, Kaufman RJ: PACE/ furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway. J Biol Chem 268:8458, 1993
15. Bristol JA, Furie BC, Furie B: Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site. J Biol Chem 268:7577, 1993
16. Davie EW, Kawabata S: A microsomal endopeptidase from liver with substrate specificity for processing proproteins such as the vitamin K-dependent proteins in plasma. J Biol Chem 267:10331, 1992
17. Hosaka M, Nagahama M, Kim W-S, Watanabe T, Hatsuzawa K, Ikemizu J, Murakami K, Nakayama K: Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J Biol Chem 266:12127, 1991
18. Seidah NG, Chrétien M: Pro-protein convertases of subtilisin/ kexin family. Methods Enzymol 244:175, 1994
19. Rehemtulla A, Kaufman RJ: Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood 79:2349, 1992
20. Oda K, Misumi Y, Ikehara Y, Brennan SO, Hatsuzawa K, Nakayama K: Proteolytic cleavages of proalbumin and complement pro-C3 in vitro by a truncated soluble form of furin, a mammalian homologue of the yeast Kex2 protease. Biochem Biophys Res Commun 189:1353, 1992
21. Giannelli F, Green PM, Sommer SS, Lillicrap DP, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG: Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994. Nucleic Acids Res 22:3534, 1994
22. Miyata T, Zheng YZ, Sakata T, Kato H: Protein C Osaka 10 with aberrant propeptide processing: loss of anticoagulant activity due to an amino acid substitution in the protein C precursor. Thromb Haemost 74:1003, 1995
23. Gandrille S, Borgel D, Eschwege-Gufflet V, Aillaud M, Dreyfus M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sie P, Toulon P, Aiach M: Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 85:130, 1995
24. -4 in the propeptide leads to incomplete γ-carboxylation and altered phospholipid binding properties. J Biol Chem 264:11401, 1989
25. Diuguid DL, Rabiet M-J, Furie BC, Liebman HA, Furie B: Molecular basis of hemophilia B: A defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. Proc Natl Acad Sci USA 83:5803, 1986
26. Sugimoto M, Miyata T, Kawabata S, Yoshioka A, Fukui H, Iwanaga S: Factor IX Kawachinagano: impaired function of the Gladomain caused by attached propeptide region due to substitution of arginine by glutamine at position -4. Br J Haematol 72:216, 1989
27. Bentley AK, Rees DJG, Rizza C, Brownlee GG; Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4. Cell 45:343, 1986
28. Wu S-M, Soute BAM, Vermeer C, Stafford DW: In vitro γ-carboxylation of a 59-residue recombinant peptide including the propeptide and the γ-carboxyglutamic acid domain of coagulation factor IX. J Biol Chem 265:13124, 1990
29. Gandrille S, Alhenc-Gelas M, Gaussem P, Aillaud M-F, Dupuy E, Juhan-Vague I, Aiach M: Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activity. Blood 82:159, 1993
30. ++. Br J Haematol 85:521, 1993
31. Gaussem P, Gandrille S, Duchemin J, Emmerich J, Alhenc-Gelas M, Aillaud M-F, Aiach M: Influence of six mutations of the protein C gene on the Gla domain conformation and calcium affinity. Thromb Haemost 71:748, 1994
32. Lind B, Van Solinge WW, Schwartz M, Thorsen S: Splice site mutation in the human protein C gene associated with venous thrombosis: Demonstration of exon skipping by ectopic transcript analysis. Blood 82:2423, 1993
33. Lind B, Schwartz M, Thorsen S: Six different point mutations in seven Danish families with symptomatic protein C deficiency. Thromb Haemost 73:186, 1995
34. Andersen BD, Lind B, Philips M, Hansen AB, Ingerslev J, Thorsen S: Two mutations in exon XII of the protein Sα gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA. Thromb Haemost 76:143, 1996
35. Philips M, Juul A-G, Selmer J, Lind B, Thorsen S: A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma - standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease. Thromb Haemost 68:486, 1992
36. Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B: Inactivation of human coagulation factor V by activated protein C. J Biol Chem 258:1914, 1983
37. Comp PC, Nixon RR, Cooper MR, Esmon CT: Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082, 1984
38. Charbonneau H: Strategies for obtaining partial amino acid sequence data, in Matsudaira PT (ed): A Practical Guide to Protein and Peptide Purification for Microsequencing. San Diego, CA, Academic, 1989, p 20
39. Cairns JR, Williamson MK, Price PA: Direct identification of γ-carboxyglutamic acid in the sequencing of vitamin K-dependent proteins. Anal Biochem 199:93, 1991
40. Edman P, Henschen A: Sequence determination, in Needleham SB (ed): Protein Sequence Determination. New York, NY, Springer-Verlag, 1975, p 239
41. Foster DC, Yoshitake S, Davie EW: The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 82:4673, 1985
42. Plutzky J, Hoskins JA, Long GL, Crabtree GR: Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 83:546, 1986
43. Stenflo J: Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood 78:1637, 1991
44. Geiger T, Clarke S: Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J Biol Chem 262:785, 1987
45. Busby SJ, Berkner KL, Halfpap LM, Gambee JE, Kumar AA: Alteration of propeptide sequence impairs biological activity of human factor VII, in Suttie JW (ed): Current Advances in Vitamin K Research. New York, NY, Elsevier Science, 1988
46. Foster DC, Rudinsky MS, Schach BG, Berkner KL, Kumar AA, Hagen FS, Sprecher CA, Insley MY, Davie EW: Propeptide of human protein C is necessary for γ-carboxylation. Biochemistry 26:7003, 1987
47. Huber P, Schmitz T, Griffin J, Jacobs M, Walsh C, Furie B, Furie BC: Identification of amino acids in the γ-carboxylation recognition site on the propeptide of prothrombin. J Biol Chem 265:12467, 1990
48. Jacobs M, Freedman SJ, Furie BC, Furie B: Membrane binding properties of the factor IX γ-carboxyglutamic acid-rich domain prepared by chemical synthesis. J Biol Chem 269:25494, 1994
49. Bristol JA, Freedman SJ, Furie BC, Furie B: Profactor IX: The propeptide inhibits binding to membrane surfaces and activation by factor XIa. Biochemistry 33:14136, 1994